Skip to main content

Table 2 FDA-approved drugs with epigenetic effects

From: Peptides as epigenetic modulators: therapeutic implications

Drugs

Classification

Indicated disease

Approved year

Procainamide

DNMTi

Cardiac arrhythmia

1950

Hydralazine

DNMTi

Hypertension

1953

Valproic acid

HDACi

Epilepsy/seizures

1978

Nesiritide

LncRNA upregulator

Heart failure

2001

Azacitidine

DNMTi

MDS

2004

Vorinostat

HDACi

CTCL

2006

Decitabine

DNMTi

MDS

2006

Romidepsin

HDACi

CTCL/PTCL

2009/2011

Ruxolitinib

JAK1/2 inhibitor

Myelofibrosis

2011

Belinostat

HDACi

PTCL

2015

Panobinostat

HDACi

MM

2015

  1. MDS myelodysplastic syndrome, CTCL cutaneous T cell lymphoma, PTCL peripheral T cell lymphoma, MM multiple myeloma